Taylor Sandison
Net Worth
Last updated:
What is Taylor Sandison net worth?
The estimated net worth of Dr. Taylor Sandison is at least $6,223,977 as of 11 Sep 2024. He owns shares worth $1,407,087 as insider, has earned $66,090 from insider trading and has received compensation worth at least $4,750,800 in Cidara Therapeutics, Inc..
What is the salary of Taylor Sandison?
Dr. Taylor Sandison salary is $593,850 per year as Chief Medical Officer in Cidara Therapeutics, Inc..
How old is Taylor Sandison?
Dr. Taylor Sandison is 53 years old, born in 1972.
What stocks does Taylor Sandison currently own?
As insider, Dr. Taylor Sandison owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) | Chief Medical Officer | 23,067 | $61 | $1,407,087 |
What does Cidara Therapeutics, Inc. do?
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Taylor Sandison insider trading
Cidara Therapeutics, Inc.
Dr. Taylor Sandison has made 5 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 924 units of CDTX stock worth $10,753 on 11 Sep 2024.
The largest trade he's ever made was exercising 25,000 units of CDTX stock on 18 Sep 2017. As of 11 Sep 2024 he still owns at least 23,067 units of CDTX stock.
Cidara Therapeutics key executives
Cidara Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Jeffrey L. Stein Ph.D. (70) Pres, Chief Executive Officer & Executive Director
- Dr. Taylor Sandison (53) Chief Medical Officer